Literature DB >> 8335061

Competitive and non competitive interactions of BQ-123 with endothelin ETA receptors.

P Vigne1, J P Breittmayer, C Frelin.   

Abstract

BQ-123 (cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]) is a competitive antagonist of the ETA receptor subtype for endothelins in aortic myocytes, and a non-competitive antagonist in human neuroblastoma cells. In the present study, using indo-1 loaded rat brain capillary endothelial cells, we demonstrate that BQ-123 acts either as a non-competitive antagonist of endothelin-1 action on [Ca2+]i depending on the experimental conditions used. A simple hypothesis to account for these results is that BQ-123 forms stable complexes with ETA receptors that are, however, less stable than the complexes formed by endothelin-1 and ETA receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335061     DOI: 10.1016/0922-4106(93)90101-e

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  The effect of PPADS as an antagonist of inositol (1,4,5)trisphosphate induced intracellular calcium mobilization.

Authors:  P Vigne; P Pacaud; V Urbach; E Feolde; J P Breittmayer; C Frelin
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery.

Authors:  W A Bax; Z Aghai; C L van Tricht; C Wassenaar; P R Saxena
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

3.  Sensitization by calyculin A of brain capillary endothelial cells to endothelin-1.

Authors:  P Vigne; J P Breittmayer; C Frelin
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.